Kinectrics is pleased to announce that the company has become a newly ratified member of the new Canadian Nuclear Isotope Council (CNIC).
The CNIC is a coalition in science, healthcare and nuclear sector organization to ensure Canada remain a World Leader in the production of life saving Isotopes, by bringing awareness and supporting long-term policies at the domestic and international level, that will save countless lives and support health care innovation for decades to come.
As the leading service provider to the CANDU fleet, Kinectrics has been involved in every aspect of CANDU technology over the years. As the fleet now moves to the production of medical Isotopes for cancer therapy, Kinectrics is poised to be at the forefront of this next evolution – producing lifesaving Isotopes. “Kinectrics is thrilled to have joined the Canadian Nuclear Isotope Council (CNIC). Our interests go far beyond what happens in the reactor, with a vision to ultimately refine and produce medical grade Isotopes in our Bruce County facilities with our partners. This is an extremely exciting time for the CANDU Industry and Kinectrics is proud to be part of this initiative, which has the potential of positively changing the lives of many of those battling cancer.” – David Harris, CEO
Since 1940, Canada has been a global leader in producing isotopes used to save lives through medical imaging, cancer therapy, sterilization, and diagnostic development. The demand for a reliable supply of these critical isotopes continues to grow with advancements in health care and as jurisdictions seek to secure fair access to diagnostics and treatments for patients as sterilization is recognized as critical to clean hospitals and infection control.
Canada has long been a historical leader in isotope production and has fostered an innovative industry that has saved millions of lives around the world. The world has come to depend on a commitment that every Canadian government has supported for over 50 years. The Government of Canada and the bipartisan Standing Committee on Natural Resources recently declared Ontario’s nuclear innovations a success story, recognizing the critical role that radioisotopes play in the global community, and stated its intention to work with industry, healthcare community, and provincial/territorial governments to ensure that the Canadian supply of radioisotopes is brought to the next level.
Isotopes are an important part of Canada’s innovation agenda, and beyond medicine, the nuclear sector contributes to a wide range of other scientific and economic activities, including energy, human health and safety, material testing, food safety, and even space exploration
Today, more than 40 per cent of the world’s single-use medical devices, such as syringes, gloves, implants and surgical instruments, are irradiated and sterilized with Cobalt-60.
The council hopes to help maintain Canada’s role as a leader in this field by encouraging innovation and investment in the radioisotope industry by industries and government.
Kinectrics is a new, entrepreneurial company—but one with a record of over 100 years of technical excellence and innovation, a tradition that continues to this day. The company continues to grow, with staff who thrive on challenges that others find daunting, and succeeds where investment in the future—in facilities, capability, and people—provides a touchstone for its vision.
From initial design and type testing to operational deployment and maintenance services, Kinectrics collaborates closely with customers to ensure that utility assistsperform safely, reliably, and efficiently throughout their entire life cycle.